Product
Placebo for PCV15 + PPSV23
1 clinical trial
1 indication
Indication
Pneumococcal InfectionClinical trial
A Phase 3, Randomized, Double-blind, Active Comparator-controlled Clinical Study to Evaluate the Safety, Tolerability, and Immunogenicity of V116 in Pneumococcal Vaccine-naïve Adults 18 to 64 Years of Age With Increased Risk for Pneumococcal DiseaseStatus: Completed, Estimated PCD: 2024-02-16